Frontlight ResearchEarly access
Enrolling by invitationNo phase
A Long-Term Extension Study for Participants Previously Treated With EB-101 for the Treatment of RDEB
Key facts
- Who runs it
- Abeona Therapeutics, Inc
- Where
- Redwood City and Worcester, United StatesSee the 2 sites
- Trial code
- Status
- Enrolling by invitation
- People taking part
- 22 people, planned
- Started
- 9 Feb 2021
- Expected to end
- Aug 2036
- Type of study
- Observational
- Treatments tested
- EB-101
- Record updated
- 17 July 2026
Who can take part
- Age
- 6 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 4 criteriaShow less
Who can take part
- Willing and able to give consent/assent
- If under the age of 18, guardian(s) is/are willing and able to give consent
- Prior study treatment with EB-101
Who cannot take part
- Inability to properly follow protocol as determined by the Principal Investigator
Where in United States
- Stanford UniversityRedwood City, United StatesEnrolling by invitation
- University of Massachusetts Medical SchoolWorcester, United StatesEnrolling by invitation
About the trial
What the trial wants to find out
A Long-Term Extension Study for Participants Previously Treated with EB-101 for the Treatment of Recessive Dystrophic Epidermolysis Bullosa (RDEB)
The group in the trial
- Long-Term Extension
This study will follow one group of participants who were enrolled in a previous EB-101 study.
Treatment: EB-101
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- A Long-Term Extension Study for Participants Previously Treated With EB-101 for the Treatment of Recessive Dystrophic Epidermolysis Bullosa (RDEB)
- Record updated
- 17 July 2026